【市場調査レポート】インスリン投与装置のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Insulin Dosing Device Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。インスリン投与装置のグローバル市場インサイト・予測（～2028年） / Global Insulin Dosing Device Market Insights, Forecast to 2028 / QY2207E09601資料のイメージです。

• レポートコード：QY2207E09601
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、115ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のインスリン投与装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインスリン投与装置の世界市場のxxx％を占める「インスリンペン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のインスリン投与装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインスリン投与装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインスリン投与装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

インスリン投与装置のグローバル主要メーカーには、Novo Nordisk、Sanofi、BD、Eli Lilly、Medtronic、Beta Bionics、Copernicus、Dance Biopharm、Debiotech、Insulet、MannKind、Owen Mumford、Roche、SOOIL、Tandem Diabetes Care、Valeritas、West Pharma、Ypsomedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

インスリン投与装置市場は、種類と用途によって区分されます。世界のインスリン投与装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
インスリンペン、インスリンポンプ、インスリン注射器、その他

【用途別セグメント】
病院、クリニック、在宅医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- インスリン投与装置製品概要
- 種類別市場（インスリンペン、インスリンポンプ、インスリン注射器、その他）
- 用途別市場（病院、クリニック、在宅医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のインスリン投与装置販売量予測2017-2028
- 世界のインスリン投与装置売上予測2017-2028
- インスリン投与装置の地域別販売量
- インスリン投与装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別インスリン投与装置販売量
- 主要メーカー別インスリン投与装置売上
- 主要メーカー別インスリン投与装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（インスリンペン、インスリンポンプ、インスリン注射器、その他）
- インスリン投与装置の種類別販売量
- インスリン投与装置の種類別売上
- インスリン投与装置の種類別価格
・用途別市場規模（病院、クリニック、在宅医療、その他）
- インスリン投与装置の用途別販売量
- インスリン投与装置の用途別売上
- インスリン投与装置の用途別価格
・北米市場
- 北米のインスリン投与装置市場規模（種類別、用途別）
- 主要国別のインスリン投与装置市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのインスリン投与装置市場規模（種類別、用途別）
- 主要国別のインスリン投与装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のインスリン投与装置市場規模（種類別、用途別）
- 主要国別のインスリン投与装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のインスリン投与装置市場規模（種類別、用途別）
- 主要国別のインスリン投与装置市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのインスリン投与装置市場規模（種類別、用途別）
- 主要国別のインスリン投与装置市場規模（トルコ、サウジアラビア）
・企業情報
Novo Nordisk、Sanofi、BD、Eli Lilly、Medtronic、Beta Bionics、Copernicus、Dance Biopharm、Debiotech、Insulet、MannKind、Owen Mumford、Roche、SOOIL、Tandem Diabetes Care、Valeritas、West Pharma、Ypsomed
・産業チェーン及び販売チャネル分析
- インスリン投与装置の産業チェーン分析
- インスリン投与装置の原材料
- インスリン投与装置の生産プロセス
- インスリン投与装置の販売及びマーケティング
- インスリン投与装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- インスリン投与装置の産業動向
- インスリン投与装置のマーケットドライバー
- インスリン投与装置の課題
- インスリン投与装置の阻害要因
・主な調査結果

Market Analysis and Insights: Global Insulin Dosing Device Market
Due to the COVID-19 pandemic, the global Insulin Dosing Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Insulin Pens accounting for % of the Insulin Dosing Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Insulin Dosing Device market size is valued at US$ million in 2021, while the US and Europe Insulin Dosing Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Insulin Dosing Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Insulin Dosing Device include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Copernicus, Dance Biopharm and Debiotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Insulin Dosing Device Scope and Segment
Insulin Dosing Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Insulin Dosing Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segment by Application
Hospital
Clinic
Home Care
Others
By Company
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
Insulet
MannKind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Insulin Dosing Device Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Dosing Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Insulin Dosing Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Dosing Device Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Dosing Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Dosing Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Dosing Device Sales by Region
2.4.1 Global Insulin Dosing Device Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Dosing Device by Region (2023-2028)
2.5 Global Insulin Dosing Device Revenue by Region
2.5.1 Global Insulin Dosing Device Revenue by Region (2017-2022)
2.5.2 Global Insulin Dosing Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Dosing Device Sales by Manufacturers
3.1.1 Global Top Insulin Dosing Device Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Dosing Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Dosing Device in 2021
3.2 Global Insulin Dosing Device Revenue by Manufacturers
3.2.1 Global Insulin Dosing Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Dosing Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Dosing Device Revenue in 2021
3.3 Global Insulin Dosing Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Dosing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Dosing Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Dosing Device Sales by Type
4.1.1 Global Insulin Dosing Device Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Dosing Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Dosing Device Sales Market Share by Type (2017-2028)
4.2 Global Insulin Dosing Device Revenue by Type
4.2.1 Global Insulin Dosing Device Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Dosing Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Dosing Device Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Dosing Device Price by Type
4.3.1 Global Insulin Dosing Device Price by Type (2017-2022)
4.3.2 Global Insulin Dosing Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Dosing Device Sales by Application
5.1.1 Global Insulin Dosing Device Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Dosing Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Dosing Device Sales Market Share by Application (2017-2028)
5.2 Global Insulin Dosing Device Revenue by Application
5.2.1 Global Insulin Dosing Device Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Dosing Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Dosing Device Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Dosing Device Price by Application
5.3.1 Global Insulin Dosing Device Price by Application (2017-2022)
5.3.2 Global Insulin Dosing Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Dosing Device Market Size by Type
6.1.1 North America Insulin Dosing Device Sales by Type (2017-2028)
6.1.2 North America Insulin Dosing Device Revenue by Type (2017-2028)
6.2 North America Insulin Dosing Device Market Size by Application
6.2.1 North America Insulin Dosing Device Sales by Application (2017-2028)
6.2.2 North America Insulin Dosing Device Revenue by Application (2017-2028)
6.3 North America Insulin Dosing Device Market Size by Country
6.3.1 North America Insulin Dosing Device Sales by Country (2017-2028)
6.3.2 North America Insulin Dosing Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Insulin Dosing Device Market Size by Type
7.1.1 Europe Insulin Dosing Device Sales by Type (2017-2028)
7.1.2 Europe Insulin Dosing Device Revenue by Type (2017-2028)
7.2 Europe Insulin Dosing Device Market Size by Application
7.2.1 Europe Insulin Dosing Device Sales by Application (2017-2028)
7.2.2 Europe Insulin Dosing Device Revenue by Application (2017-2028)
7.3 Europe Insulin Dosing Device Market Size by Country
7.3.1 Europe Insulin Dosing Device Sales by Country (2017-2028)
7.3.2 Europe Insulin Dosing Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Dosing Device Market Size by Type
8.1.1 Asia Pacific Insulin Dosing Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Dosing Device Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Dosing Device Market Size by Application
8.2.1 Asia Pacific Insulin Dosing Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Dosing Device Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Dosing Device Market Size by Region
8.3.1 Asia Pacific Insulin Dosing Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Dosing Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Dosing Device Market Size by Type
9.1.1 Latin America Insulin Dosing Device Sales by Type (2017-2028)
9.1.2 Latin America Insulin Dosing Device Revenue by Type (2017-2028)
9.2 Latin America Insulin Dosing Device Market Size by Application
9.2.1 Latin America Insulin Dosing Device Sales by Application (2017-2028)
9.2.2 Latin America Insulin Dosing Device Revenue by Application (2017-2028)
9.3 Latin America Insulin Dosing Device Market Size by Country
9.3.1 Latin America Insulin Dosing Device Sales by Country (2017-2028)
9.3.2 Latin America Insulin Dosing Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Insulin Dosing Device Market Size by Type
10.1.1 Middle East and Africa Insulin Dosing Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Dosing Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Dosing Device Market Size by Application
10.2.1 Middle East and Africa Insulin Dosing Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Dosing Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Dosing Device Market Size by Country
10.3.1 Middle East and Africa Insulin Dosing Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Dosing Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Medtronic
11.5.1 Medtronic Corporation Information
11.5.2 Medtronic Overview
11.5.3 Medtronic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Medtronic Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Medtronic Recent Developments
11.6 Beta Bionics
11.6.1 Beta Bionics Corporation Information
11.6.2 Beta Bionics Overview
11.6.3 Beta Bionics Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Beta Bionics Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Beta Bionics Recent Developments
11.7 Copernicus
11.7.1 Copernicus Corporation Information
11.7.2 Copernicus Overview
11.7.3 Copernicus Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Copernicus Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Copernicus Recent Developments
11.8 Dance Biopharm
11.8.1 Dance Biopharm Corporation Information
11.8.2 Dance Biopharm Overview
11.8.3 Dance Biopharm Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dance Biopharm Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dance Biopharm Recent Developments
11.9 Debiotech
11.9.1 Debiotech Corporation Information
11.9.2 Debiotech Overview
11.9.3 Debiotech Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Debiotech Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Debiotech Recent Developments
11.10 Insulet
11.10.1 Insulet Corporation Information
11.10.2 Insulet Overview
11.10.3 Insulet Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Insulet Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Insulet Recent Developments
11.11 MannKind
11.11.1 MannKind Corporation Information
11.11.2 MannKind Overview
11.11.3 MannKind Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 MannKind Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 MannKind Recent Developments
11.12 Owen Mumford
11.12.1 Owen Mumford Corporation Information
11.12.2 Owen Mumford Overview
11.12.3 Owen Mumford Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Owen Mumford Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Owen Mumford Recent Developments
11.13 Roche
11.13.1 Roche Corporation Information
11.13.2 Roche Overview
11.13.3 Roche Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Roche Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Roche Recent Developments
11.14 SOOIL
11.14.1 SOOIL Corporation Information
11.14.2 SOOIL Overview
11.14.3 SOOIL Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 SOOIL Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 SOOIL Recent Developments
11.15 Tandem Diabetes Care
11.15.1 Tandem Diabetes Care Corporation Information
11.15.2 Tandem Diabetes Care Overview
11.15.3 Tandem Diabetes Care Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tandem Diabetes Care Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tandem Diabetes Care Recent Developments
11.16 Valeritas
11.16.1 Valeritas Corporation Information
11.16.2 Valeritas Overview
11.16.3 Valeritas Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Valeritas Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Valeritas Recent Developments
11.17 West Pharma
11.17.1 West Pharma Corporation Information
11.17.2 West Pharma Overview
11.17.3 West Pharma Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 West Pharma Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 West Pharma Recent Developments
11.18 Ypsomed
11.18.1 Ypsomed Corporation Information
11.18.2 Ypsomed Overview
11.18.3 Ypsomed Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Ypsomed Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Ypsomed Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Dosing Device Industry Chain Analysis
12.2 Insulin Dosing Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Dosing Device Production Mode & Process
12.4 Insulin Dosing Device Sales and Marketing
12.4.1 Insulin Dosing Device Sales Channels
12.4.2 Insulin Dosing Device Distributors
12.5 Insulin Dosing Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Dosing Device Industry Trends
13.2 Insulin Dosing Device Market Drivers
13.3 Insulin Dosing Device Market Challenges
13.4 Insulin Dosing Device Market Restraints
14 Key Findings in The Global Insulin Dosing Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Insulin Dosing Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Insulin Pens
Table 3. Major Manufacturers of Insulin Pumps
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Others
Table 6. Global Insulin Dosing Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Insulin Dosing Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Insulin Dosing Device Sales by Region (2017-2022) & (K Units)
Table 9. Global Insulin Dosing Device Sales Market Share by Region (2017-2022)
Table 10. Global Insulin Dosing Device Sales by Region (2023-2028) & (K Units)
Table 11. Global Insulin Dosing Device Sales Market Share by Region (2023-2028)
Table 12. Global Insulin Dosing Device Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Insulin Dosing Device Revenue Market Share by Region (2017-2022)
Table 14. Global Insulin Dosing Device Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Insulin Dosing Device Revenue Market Share by Region (2023-2028)
Table 16. Global Insulin Dosing Device Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Insulin Dosing Device Sales Share by Manufacturers (2017-2022)
Table 18. Global Insulin Dosing Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Insulin Dosing Device Revenue Share by Manufacturers (2017-2022)
Table 20. Insulin Dosing Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Insulin Dosing Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Insulin Dosing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Dosing Device as of 2021)
Table 23. Insulin Dosing Device Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Insulin Dosing Device Product Offered
Table 25. Date of Manufacturers Enter into Insulin Dosing Device Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 28. Global Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 29. Global Insulin Dosing Device Sales Share by Type (2017-2022)
Table 30. Global Insulin Dosing Device Sales Share by Type (2023-2028)
Table 31. Global Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Insulin Dosing Device Revenue Share by Type (2017-2022)
Table 34. Global Insulin Dosing Device Revenue Share by Type (2023-2028)
Table 35. Insulin Dosing Device Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Insulin Dosing Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 38. Global Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 39. Global Insulin Dosing Device Sales Share by Application (2017-2022)
Table 40. Global Insulin Dosing Device Sales Share by Application (2023-2028)
Table 41. Global Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Insulin Dosing Device Revenue Share by Application (2017-2022)
Table 44. Global Insulin Dosing Device Revenue Share by Application (2023-2028)
Table 45. Insulin Dosing Device Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Insulin Dosing Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 48. North America Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 49. North America Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 52. North America Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 53. North America Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Insulin Dosing Device Sales by Country (2017-2022) & (K Units)
Table 56. North America Insulin Dosing Device Sales by Country (2023-2028) & (K Units)
Table 57. North America Insulin Dosing Device Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Insulin Dosing Device Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 60. Europe Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 61. Europe Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 64. Europe Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 65. Europe Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Insulin Dosing Device Sales by Country (2017-2022) & (K Units)
Table 68. Europe Insulin Dosing Device Sales by Country (2023-2028) & (K Units)
Table 69. Europe Insulin Dosing Device Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Insulin Dosing Device Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Insulin Dosing Device Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Insulin Dosing Device Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Insulin Dosing Device Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Insulin Dosing Device Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Insulin Dosing Device Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Insulin Dosing Device Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Insulin Dosing Device Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Insulin Dosing Device Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Insulin Dosing Device Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Insulin Dosing Device Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Insulin Dosing Device Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Insulin Dosing Device Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Insulin Dosing Device Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Insulin Dosing Device Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Insulin Dosing Device Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Insulin Dosing Device Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Insulin Dosing Device Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Insulin Dosing Device Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Insulin Dosing Device Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Insulin Dosing Device Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novo Nordisk Corporation Information
Table 108. Novo Nordisk Description and Major Businesses
Table 109. Novo Nordisk Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Novo Nordisk Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novo Nordisk Recent Developments
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Major Businesses
Table 114. Sanofi Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Sanofi Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sanofi Recent Developments
Table 117. BD Corporation Information
Table 118. BD Description and Major Businesses
Table 119. BD Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. BD Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BD Recent Developments
Table 122. Eli Lilly Corporation Information
Table 123. Eli Lilly Description and Major Businesses
Table 124. Eli Lilly Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Eli Lilly Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Eli Lilly Recent Developments
Table 127. Medtronic Corporation Information
Table 128. Medtronic Description and Major Businesses
Table 129. Medtronic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Medtronic Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Medtronic Recent Developments
Table 132. Beta Bionics Corporation Information
Table 133. Beta Bionics Description and Major Businesses
Table 134. Beta Bionics Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Beta Bionics Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Beta Bionics Recent Developments
Table 137. Copernicus Corporation Information
Table 138. Copernicus Description and Major Businesses
Table 139. Copernicus Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Copernicus Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Copernicus Recent Developments
Table 142. Dance Biopharm Corporation Information
Table 143. Dance Biopharm Description and Major Businesses
Table 144. Dance Biopharm Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Dance Biopharm Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Dance Biopharm Recent Developments
Table 147. Debiotech Corporation Information
Table 148. Debiotech Description and Major Businesses
Table 149. Debiotech Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Debiotech Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Debiotech Recent Developments
Table 152. Insulet Corporation Information
Table 153. Insulet Description and Major Businesses
Table 154. Insulet Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Insulet Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Insulet Recent Developments
Table 157. MannKind Corporation Information
Table 158. MannKind Description and Major Businesses
Table 159. MannKind Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. MannKind Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. MannKind Recent Developments
Table 162. Owen Mumford Corporation Information
Table 163. Owen Mumford Description and Major Businesses
Table 164. Owen Mumford Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Owen Mumford Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Owen Mumford Recent Developments
Table 167. Roche Corporation Information
Table 168. Roche Description and Major Businesses
Table 169. Roche Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Roche Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Roche Recent Developments
Table 172. SOOIL Corporation Information
Table 173. SOOIL Description and Major Businesses
Table 174. SOOIL Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. SOOIL Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. SOOIL Recent Developments
Table 177. Tandem Diabetes Care Corporation Information
Table 178. Tandem Diabetes Care Description and Major Businesses
Table 179. Tandem Diabetes Care Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Tandem Diabetes Care Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Tandem Diabetes Care Recent Developments
Table 182. Valeritas Corporation Information
Table 183. Valeritas Description and Major Businesses
Table 184. Valeritas Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Valeritas Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Valeritas Recent Developments
Table 187. West Pharma Corporation Information
Table 188. West Pharma Description and Major Businesses
Table 189. West Pharma Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. West Pharma Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. West Pharma Recent Developments
Table 192. Ypsomed Corporation Information
Table 193. Ypsomed Description and Major Businesses
Table 194. Ypsomed Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. Ypsomed Insulin Dosing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Ypsomed Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Insulin Dosing Device Distributors List
Table 200. Insulin Dosing Device Customers List
Table 201. Insulin Dosing Device Market Trends
Table 202. Insulin Dosing Device Market Drivers
Table 203. Insulin Dosing Device Market Challenges
Table 204. Insulin Dosing Device Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Dosing Device Product Picture
Figure 3. Global Insulin Dosing Device Market Share by Type in 2021 & 2028
Figure 3. Insulin Pens Product Picture
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Syringes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Insulin Dosing Device Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Home Care
Figure 11. Others
Figure 12. Insulin Dosing Device Report Years Considered
Figure 13. Global Insulin Dosing Device Sales 2017-2028 (K Units)
Figure 14. Global Insulin Dosing Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Insulin Dosing Device Revenue 2017-2028 (US$ Million)
Figure 16. Global Insulin Dosing Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Insulin Dosing Device Sales Market Share by Region (2017-2022)
Figure 18. Global Insulin Dosing Device Sales Market Share by Region (2023-2028)
Figure 19. North America Insulin Dosing Device Sales YoY (2017-2028) & (K Units)
Figure 20. North America Insulin Dosing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Insulin Dosing Device Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Insulin Dosing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Insulin Dosing Device Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Insulin Dosing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Insulin Dosing Device Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Insulin Dosing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Insulin Dosing Device Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Insulin Dosing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Insulin Dosing Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Insulin Dosing Device in the World: Market Share by Insulin Dosing Device Revenue in 2021
Figure 31. Global Insulin Dosing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 33. Global Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 34. Global Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 35. Global Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 36. North America Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 37. North America Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 38. North America Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 39. North America Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 40. North America Insulin Dosing Device Sales Share by Country (2017-2028)
Figure 41. North America Insulin Dosing Device Revenue Share by Country (2017-2028)
Figure 42. United States Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 45. Europe Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 46. Europe Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 47. Europe Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 48. Europe Insulin Dosing Device Sales Share by Country (2017-2028)
Figure 49. Europe Insulin Dosing Device Revenue Share by Country (2017-2028)
Figure 50. Germany Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 51. France Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Insulin Dosing Device Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Insulin Dosing Device Revenue Share by Region (2017-2028)
Figure 61. China Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 64. India Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 71. Latin America Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 73. Latin America Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Insulin Dosing Device Sales Share by Country (2017-2028)
Figure 75. Latin America Insulin Dosing Device Revenue Share by Country (2017-2028)
Figure 76. Mexico Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Insulin Dosing Device Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Insulin Dosing Device Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Insulin Dosing Device Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Insulin Dosing Device Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Insulin Dosing Device Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Insulin Dosing Device Revenue Share by Country (2017-2028)
Figure 86. Turkey Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Insulin Dosing Device Revenue (2017-2028) & (US$ Million)
Figure 89. Insulin Dosing Device Value Chain
Figure 90. Insulin Dosing Device Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Global Home Insulin Delivery (Dosing) Devices Market Insights, Forecast to 2028
QY2207E09542 2022年7月 128Pages
新型コロナウイルス感染症のパンデミックにより、世界の家庭用インスリンデリバリー（投薬）装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年...

スマートインスリン注射器のグローバル市場インサイト・予測（～2028年）

Global Smart Insulin Injection Pens Market Insights, Forecast to 2028
QY2207E10099 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のスマートインスリン注射器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスマートイン...

動物健康管理用注射器のグローバル市場インサイト・予測（～2028年）

Global Animal Health Dosing Syringe Market Insights, Forecast to 2028
QY2207E09431 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の動物健康管理用注射器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に動物健康管理用注...

局所計量投与ディスペンサーのグローバル市場インサイト・予測（～2028年）

Global Topical Metered Dosing Dispenser Market Insights, Forecast to 2028
QY2207E10177 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の局所計量投与ディスペンサーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に局所計量投...

経口インスリンのグローバル市場インサイト・予測（～2028年）

Global Oral Insulin Market Insights, Forecast to 2028
QY2207E10442 2022年7月 86Pages
新型コロナウイルス感染症のパンデミックにより、世界の経口インスリンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口インスリンの世界市...

家庭用インスリンデリバリー（投薬）装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Home Insulin Delivery (Dosing) Devices Market Due to the COVID-19 pandemic, the global Home Insulin Delivery (Dosing) Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % dur…
スマートインスリンペン＆ポンプの世界市場2022年-2030年 Summary: In this Smart Insulin Pens & Pumps Market report, offers a comprehensive analysis of key market trends in the global Smart Insulin Pens & Pumps market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which a…
スマートインスリン注射器のグローバル市場インサイト・予測（～2028年） The smart insulin injection pen is a reusable syringe pen with an intuitive smartphone app that helps people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts and reports. Market Analysis and Insights: Global Smart Insu…
経口インスリンのグローバル市場インサイト・予測（～2028年） The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoida…
スプリットインスリンポンプのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Split Insulin Pump Market Due to the COVID-19 pandemic, the global Split Insulin Pump market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully…